Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD

详细信息    查看全文

• 作者：David A. Wolk^a ; ^b ; ^{david.wolk@uphs.upenn.edu} ; Lauren Mancuso^a ; ^b ; Daria Kliot^a ; ^b ; Steven E. Arnold^a ; ^b ; ^c ; Bradford C. Dickerson^d ; ^e ; ^f ; ^g
• 关键词：Memory ; Recollection ; Familiarity ; Alzheimer's disease ; Medial temporal lobe ; Preclinical Alzheimer's disease ; Mild cognitive impairment
• 刊名：Neuropsychologia
• 出版年：2013
• 出版时间：May, 2013
• 年：2013
• 卷：51
• 期：6
• 页码：1094-1102
• 全文大小：374 K

文摘

There is great interest in the development of cognitive markers that differentiate ¡°normal¡± age-associated cognitive change from that of Alzheimer's disease (AD) in its prodromal (i.e., mild cognitive impairment; MCI) or even preclinical stages. Dual process models posit that recognition memory is supported by the dissociable processes of recollection and familiarity. Familiarity-based memory has generally been considered to be spared during normal aging, but it remains controversial whether this type of memory is impaired in early AD. Here, we describe findings of estimates of recollection and familiarity in young adults (YA), cognitively normal older adults (CN), and patients with amnestic-MCI (a-MCI). These measures in the CN and a-MCI patients were then related to a structural imaging biomarker of AD that has previously been demonstrated to be sensitive to preclinical and prodromal AD, the Cortical Signature of AD (ADsig). Consistent with much work in the literature, recollection, but not familiarity, was impaired in CN versus YA. Replicating our prior findings, a-MCI patients displayed impairment in both familiarity and recollection. Finally, the familiarity measure was correlated with the ADsig biomarker across the CN and a-MCI group, as well as within the CN adults alone. No other standard psychometric measure was as highly associated with the ADsig, suggesting that familiarity may be a sensitive biomarker of AD-specific brain changes in preclinical and prodromal AD and that it may offer a qualitatively distinct measure of early AD memory impairment relative to normal age-associated change.